Trademark: 86724536
Status Date
Monday, January 21, 2019
Filing Date
Thursday, August 13, 2015
Published for Opposition
Tuesday, February 23, 2016
Abandoned Date
Monday, January 21, 2019
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to sensory organs; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Jan 22, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 21, 2019
Abandonment - No Use Statement Filed
Jan 19, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 18, 2019
Extension 4 Granted
Apr 13, 2018
Extension 4 Filed
Oct 20, 2018
Response To Itu Office Action Entered
Jan 18, 2019
Review Of Correspondence Complete
Oct 20, 2018
Teas Post Publication Amendment Received
Sep 4, 2018
Teas Response To Office Action Received
Aug 10, 2018
Itu Office Action Issued For Extension Request
Apr 13, 2018
Teas Extension Received
Jan 3, 2018
Assignment Of Ownership Not Updated Automatically
Oct 7, 2017
Notice Of Approval Of Extension Request E-Mailed
Oct 5, 2017
Extension 3 Granted
Oct 5, 2017
Extension 3 Filed
Oct 5, 2017
Teas Extension Received
Mar 30, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 29, 2017
Automatic Update Of Assignment Of Ownership
Mar 29, 2017
Extension 2 Granted
Mar 22, 2017
Extension 2 Filed
Mar 29, 2017
Case Assigned To Intent To Use Paralegal
Mar 22, 2017
Teas Extension Received
Jan 30, 2017
Teas Change Of Correspondence Received
Oct 12, 2016
Notice Of Approval Of Extension Request E-Mailed
Oct 10, 2016
Extension 1 Granted
Oct 10, 2016
Extension 1 Filed
Oct 10, 2016
Teas Extension Received
Apr 19, 2016
Noa E-Mailed - Sou Required From Applicant
Feb 23, 2016
Official Gazette Publication Confirmation E-Mailed
Feb 23, 2016
Published For Opposition
Feb 3, 2016
Notification Of Notice Of Publication E-Mailed
Dec 2, 2015
Approved For Pub - Principal Register
Dec 2, 2015
Examiner's Amendment Entered
Dec 2, 2015
Notification Of Examiners Amendment E-Mailed
Dec 2, 2015
Examiners Amendment E-Mailed
Dec 2, 2015
Examiners Amendment -Written
Nov 27, 2015
Assigned To Examiner
Aug 19, 2015
New Application Office Supplied Data Entered In Tram
Aug 17, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
